CCI Testing Method Development For Vials Stored At -80C, Using Headspace Gas Ingress
By Allison Alix, Application Scientist, Lighthouse Instruments
Sterile pharmaceutical products such as live viral vaccines, gene therapies, and products that contain active cells often require deep cold storage, either at -80°C or cryogenic temperatures (-196°C) to maintain stability and/or activity. These storage conditions pose a challenge to the packaging components; in particular to the sealing performance of the vial/rubber stopper combinations traditionally used to package these products. It is therefore essential to generate robust data that demonstrates the maintenance of seal integrity during deep cold storage and/or transport which, in turn, requires a robust container closure integrity (CCI) test method. This article describes the development of such a test method for vials stored at -80°C.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.